Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.
2.

Response to methotrexate predicts long-term mortality of patients with rheumatoid arthritis independent of the degree of response: results of a re-evaluation 30 years after baseline.

Krause C, Herborn G, Braun J, Rudolf H, Wassenberg S, Rau R, Krause D.

Clin Exp Rheumatol. 2017 May-Jun;35(3):384-389. Epub 2016 Dec 13.

PMID:
27974101
3.

Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis.

Barrera P, van der Maas A, van Ede AE, Kiemeney BA, Laan RF, van de Putte LB, van Riel PL.

Rheumatology (Oxford). 2002 Apr;41(4):430-9.

PMID:
11961174
4.

Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis.

Krause D, Gabriel B, Herborn G, Braun J, Rau R.

Clin Exp Rheumatol. 2015 Sep-Oct;33(5):611-6. Epub 2015 Aug 27.

PMID:
26315962
6.
7.

The methotrexate therapeutic response in rheumatoid arthritis.

Ortendahl M, Holmes T, Schettler JD, Fries JF.

J Rheumatol. 2002 Oct;29(10):2084-91.

PMID:
12375316
9.

Methotrexate for treating rheumatoid arthritis.

Lopez-Olivo MA, Siddhanamatha HR, Shea B, Tugwell P, Wells GA, Suarez-Almazor ME.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD000957. doi: 10.1002/14651858.CD000957.pub2. Review.

PMID:
24916606
10.

Time to methotrexate treatment in patients with rheumatoid arthritis referred to hospital.

de Thurah A, Nørgaard M, Johansen M, Stengaard-Pedersen K.

Scand J Rheumatol. 2010;39(1):19-25. doi: 10.3109/03009740903185987.

PMID:
20132066
11.

Association of dihydrofolate reductase (DHFR) -317AA genotype with poor response to methotrexate in patients with rheumatoid arthritis.

Milic V, Jekic B, Lukovic L, Bunjevacki V, Milasin J, Novakovic I, Damnjanovic T, Popovic B, Maksimovic N, Damjanov N, Radunovic G, Pejnovic N, Krajinovic M.

Clin Exp Rheumatol. 2012 Mar-Apr;30(2):178-83. Epub 2012 Apr 13.

PMID:
22324981
12.

Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis.

Krause D, Gabriel B, Herborn G, Braun J, Rau R.

Clin Rheumatol. 2016 May;35(5):1123-7. doi: 10.1007/s10067-016-3216-y. Epub 2016 Feb 26.

PMID:
26920753
13.

Effectiveness, tolerability, and safety of subcutaneous methotrexate in early rheumatoid arthritis: A retrospective analysis of real-world data from the St. Gallen cohort.

Müller RB, von Kempis J, Haile SR, Schiff MH.

Semin Arthritis Rheum. 2015 Aug;45(1):28-34. doi: 10.1016/j.semarthrit.2015.02.009. Epub 2015 Mar 3.

PMID:
25895697
14.

Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Shea B, Swinden MV, Tanjong Ghogomu E, Ortiz Z, Katchamart W, Rader T, Bombardier C, Wells GA, Tugwell P.

Cochrane Database Syst Rev. 2013 May 31;(5):CD000951. doi: 10.1002/14651858.CD000951.pub2. Review.

PMID:
23728635
15.

Randomized controlled trial comparing 2 different starting doses of methotrexate in rheumatoid arthritis.

Dhir V, Singla M, Gupta N, Goyal P, Sagar V, Sharma A, Khanna S, Singh S.

Clin Ther. 2014 Jul 1;36(7):1005-15. doi: 10.1016/j.clinthera.2014.05.063. Epub 2014 Jun 26.

PMID:
24976447
16.

Propensity-adjusted association of methotrexate with overall survival in rheumatoid arthritis.

Wasko MC, Dasgupta A, Hubert H, Fries JF, Ward MM.

Arthritis Rheum. 2013 Feb;65(2):334-42. doi: 10.1002/art.37723. Erratum in: Arthritis Rheum. 2013 May;65(5):1231.

17.
18.

Concomitant Methotrexate Protects Against Total Knee Arthroplasty in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors.

Asai S, Takahashi N, Funahashi K, Yoshioka Y, Takemoto T, Terabe K, Asai N, Ishiguro N, Kojima T.

J Rheumatol. 2015 Dec;42(12):2255-60. doi: 10.3899/jrheum.150410. Epub 2015 Oct 1.

PMID:
26428206
19.

Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.

Keystone EC, van der Heijde D, Kavanaugh A, Kupper H, Liu S, Guérette B, Mozaffarian N.

J Rheumatol. 2013 Sep;40(9):1487-97. doi: 10.3899/jrheum.120964. Epub 2013 Jul 1.

20.

A clinical study of CPH 82 vs methotrexate in early rheumatoid arthritis.

Lerndal T, Svensson B.

Rheumatology (Oxford). 2000 Mar;39(3):316-20.

PMID:
10788542

Supplemental Content

Support Center